Currently, serum biomarkers, such as alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH), and the Tumor Node Metastasis (TNM) classification were used to assist to make treatment decisions for TGCT patients6. Here, AFP is linked to neoplasm.